The private equity group Permira has bid to acquire LivaNova, the US-listed medical devices manufacturer, two people familiar with the matter said.
The offer, made in mid-February, values the company’s shares at more than $80, the people said. That marks a premium to their $75 price on Wednesday, which gave the company a $3.7bn market value.
Talks are ongoing but there is no certainty that a deal will be reached, the people cautioned.
LivaNova produces medical equipment such as life-support machines, heart valves and oxygenators and has nearly 4,000 staff, according to its website. It is based in London but listed on the Nasdaq stock exchange. It delisted from the London Stock Exchange in 2017.
Source: The Financial Times
By Kaye Wiggins and Bryce Elder
Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.